GOODWILL AND OTHER INTANGIBLE ASSETS

6 Months Ended

Jun. 30, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

NOTE 9. GOODWILL AND OTHER INTANGIBLE ASSETS

The following table summarizes intangible assets by category (in thousands):



	June 30, 2016							December 31, 2015
	Gross Amount		Accumulated Amortization			Net Amount		Gross Amount		Accumulated Amortization			Net Amount
Finite-lived intangible assets
Domain names	$	4,200	$	(1,357	)	$	2,843	$	4,200	$	(1,160	)	$	3,040
Customer relationships	23,866		(4,181		)	19,685		23,866		(1,973		)	21,893
Media broadcast rights	1,350		(248		)	1,102		1,350		(113		)	1,237
Acquired technology	436		(189		)	247		436		(145		)	291
Other intangible assets	68		(48		)	20		68		(38		)	30
	$	29,920	$	(6,023	)	$	23,897	$	29,920	$	(3,429	)	$	26,491
Indefinite-lived intangible assets
Trademarks and trade names	$	8,276				$	8,276	$	8,276				$	8,276
License to operate in China	100					100		100					100
Total intangible assets	$	38,296				$	32,273	$	38,296				$	34,867

Total amortization expense was $2.6 million and $0.4 million for the six months ended June 30, 2016 and 2015, respectively.

The following table summarizes the changes in goodwill during the six months ended June 30, 2016 and the year ended December 31, 2015 (in thousands):



	Six Months Ended June 30, 2016						Year Ended December 31, 2015
	Travel and Entertainment Segment		Corporate Entity and Other Business Units		Total		Travel and Entertainment Segment		Corporate Entity and Other Business Units		Total
Balance at beginning of period	$	18,514	$	1,823	$	20,337	$	3,470	$	1,823	$	5,293
Business acquisitions	—		—		—		15,044		—		15,044
Balance at end of period	$	18,514	$	1,823	$	20,337	$	18,514	$	1,823	$	20,337

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details